Publications by authors named "Sean Dulloo"

Claim this Profile
D
Decentralising delivery of systemic anti-cancer therapy (SACT) with subcutaneous atezolizumab: service challenges, opportunities and case studies.
Elaine Tomlins, Helen Winter, Anna Olsson-Brown, Jenna Robinson, Sally Long, Sean Dulloo

Br J Nurs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decentralising delivery of systemic anti-cancer therapy (SACT) with subcutaneous atezolizumab: service challenges, opportunities and case studies.
Joseph Williams, Elaine Tomlins, Helen Winter, Anna Olsson-Brown, Jenna Robinson, Sean Dulloo

Br J Nurs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cranial nerve III palsy induced by adjuvant capecitabine for cholangiocarcinoma.
Maurice Dungey, Norene Ashmore, Sean Dulloo

BMJ Case Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA Damage Response Deficiency in Thoracic Cancers.
Aleksandra Bzura, Jake B Spicer, Sean Dulloo, Timothy A Yap, Dean A Fennell

Drugs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.
Dean Fennell, Daniel Griffiths, Zina Eminton, Abigail Morgan-Fox, Kayleigh Hill, Sean Dulloo

BMJ Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy approaches for malignant pleural mesothelioma.
Dean A Fennell, Sean Dulloo, James Harber

Nat Rev Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma.
Dean A Fennell, Sean Dulloo

J Thorac Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Therapy for Mesothelioma: Feasibility and New Opportunities.
Sean Dulloo, Aleksandra Bzura, Dean Anthony Fennell

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis